Sol Gel Technologies Ltd
NASDAQ:SLGL
Sol Gel Technologies Ltd
Other
Sol Gel Technologies Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Other
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Other
-$337m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-132%
|
CAGR 10-Years
-7%
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Other
-$859k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Other
-$214k
|
CAGR 3-Years
52%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seach Medical Group Ltd
TASE:SEMG
|
Other
-₪917k
|
CAGR 3-Years
-122%
|
CAGR 5-Years
-152%
|
CAGR 10-Years
N/A
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sol Gel Technologies Ltd
Glance View
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
See Also
What is Sol Gel Technologies Ltd's Other?
Other
0
USD
Based on the financial report for Sep 30, 2025, Sol Gel Technologies Ltd's Other amounts to 0 USD.
